Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Completed · Phase 2
Conditions studied: Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
In brief
RATIONALE: Umbilical cord blood transplantation may allow doctors to give higher doses of chemotherapy or radiation therapy and kill more cancer cells. PURPOSE: This phase II trial is studying allogeneic umbilical cord blood transplantation to see how well it works when given with chemotherapy or radiation therapy in treating patients with high-risk hematologic cancer.
Key facts
- Study ID
- NCT00003335
- Run by
- Case Comprehensive Cancer Center
- People needed
- 44
- Starts
- 1998-01-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2012-03-15
Who can join
Age: any, up to 54. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.